Actively Recruiting
Study on Multibranched Stent Graft System in the Treatment of Thoracoabdominal Aortic Aneurysm
Led by Lifetech Scientific (Shenzhen) Co., Ltd. · Updated on 2024-07-12
73
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this study is to evaluate the feasibility of multibranched stent graft system for Endovascular Treatment of Thoracoabdominal Aortic Aneurysm(TAAA)
CONDITIONS
Official Title
Study on Multibranched Stent Graft System in the Treatment of Thoracoabdominal Aortic Aneurysm
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 to 80 years
- Diagnosed with thoracoabdominal aortic aneurysm meeting criteria such as maximum diameter over 50 mm, rapid growth, or related symptoms
- Anatomical suitability for stent graft including specific landing zone diameters and lengths
- Feasible iliofemoral artery and upper extremity access
- Ability to understand the trial, voluntarily participate, sign informed consent, and complete follow-up
You will not qualify if you...
- Ruptured aortic aneurysm with unstable condition
- Aneurysmal aortic dissection
- Infected or mycotic aortic aneurysm
- Systemic or local infection increasing graft infection risk
- Occlusion of major arteries such as superior mesenteric, celiac trunk, or renal artery
- Need for simultaneous coverage or embolisation of both internal iliac arteries
- Severe stenosis, calcification, or thrombus at stent-graft landing zone
- Acute coronary syndrome within 6 months
- Transient ischemic attack or ischemic stroke within 3 months
- Significant liver or kidney function abnormalities
- Severe pulmonary insufficiency preventing general anesthesia
- Severe coagulation dysfunction
- Major surgery or intervention within 30 days prior
- Allergy to contrast agents, anticoagulants, antiplatelets, stent graft materials, or delivery system components
- Connective tissue diseases such as lupus, Marfan syndrome, Ehlers-Danlos syndrome, or Behcet's disease
- Takayasu arteritis
- Serious vital organ dysfunction or other severe diseases
- Pregnancy, planning pregnancy, or breastfeeding
- Participation in other clinical trials within last 3 months
- Life expectancy less than 1 year
- Not suitable for endovascular repair based on investigator judgment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chinese PLA General Hospital
Beijing, China
Actively Recruiting
Research Team
W
Wei Xu, PM
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here